前沿论文｜CELL INTELLIGENCE

Anti-HER2/neu TCR-T Cells in Action: linking transcriptional signatures, secretomics, and In Vivo tumor suppression.

PubMed 2025/11/25 发表Front ImmunolQ1 · IF 7（JCR 2025）

58.5分

★★★☆☆

站内排序·非疗效

Full-length recombinant antibodies from Escherichia coli: production, characterization, effector function (Fc) engineering, and clinical evaluation.

PubMed 2022/01/01 发表MAbsQ1 · IF 7.9（JCR 2025）

46.9分

★★★☆☆

站内排序·非疗效

前沿论文 2